Press "Enter" to skip to content

New patent for NOVO drug OZEMPIC

2
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug OZEMPIC

Annual Drug Patent Expirations for OZEMPIC
Annual Drug Patent Expirations for OZEMPIC

Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-two patents protecting this drug.

OZEMPIC drug price trends.

Drug patent litigation for OZEMPIC.

This drug has one hundred and ninety-nine patent family members in twenty-eight countries.

The generic ingredient in OZEMPIC is semaglutide. Three suppliers are listed for this compound. Additional details are available on the semaglutide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug OZEMPIC
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!